Sanofi SA vs Yum China Holdings Inc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Yum China Holdings Inc trades at $43.91 (market cap $15.09B). The key difference: Sanofi SA is far larger — about 6.9× Yum China Holdings Inc's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | YUMC | |
|---|---|---|
Market Cap | $104.83B | $15.09B |
Sector | Health | Consumer Cyclical |
52-Week High | $52.34 | $57.95 |
52-Week Low | $41.33 | $40.18 |
Enterprise Value | $121.32B | $15.98B |
Dividend Yield | 5.5% | 2.64% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →